At least, some of the CD44 variants are associated with cancer aggressive behavior, such as radioresistance, chemoresistance and metastases, and correlate with poor prognosis in a variety of human malignancies, including colorectal cancer [17,32,33,34,35]. The gene discussed is CD44; the disease is colorectal cancer.